Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03681119 · ClinicalTrials.gov registry record · NA
The Hospice Advanced Dementia Symptom Management and Quality of Life Trial
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 83
- Enrollment target
NCT03681119 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 83 participants.
The verdict
NCT03681119, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 83 participants
- Enrollment target
Study Summary
Alzheimer's Disease and Related Disorders (dementia) are a group of serious life limiting illness that cause significant challenges to our public health system, with significant illness burden for both the person with dementia and the caregiver. At the end of life, over 230,000 persons with dementia annually are cared for in hospice, yet hospice agencies are ill prepared to care for this population and often resort to inappropriate pharmacologic measures such as antipsychotics that reduce quality of life rather than improve it. This study will therefore through its two phases refine and then implement, using a pragmatic stepped wedge trial design, the Dementia Symptom Management at Home Program Hospice Edition, with the goal improving quality of care for the person with dementia and their caregiver, reducing antipsychotic use, and increasing bereaved caregiver satisfaction in the hospice setting.
Interventions
- BEHAVIORAL Dementia symptom management at home hospice edition
- BEHAVIORAL Education and Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 83 participants |
| Start Date | 2019-02-11 |
| Est. Completion | 2019-06-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03681119
The ClinicalTrials.gov registry entry for NCT03681119 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 83 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dementia symptom management at home hospice edition is the first listed.
NCT03681119 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03681119 about?
NCT03681119 is a clinical study titled "The Hospice Advanced Dementia Symptom Management and Quality of Life Trial". Alzheimer's Disease and Related Disorders (dementia) are a group of serious life limiting illness that cause significant challenges to our public health system, with significant illness burden for both the person with dementia and the caregiver. At the end of life, over 230,000 persons with dementia...
What is the current status of trial NCT03681119?
This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2019-02-11. Estimated completion is 2019-06-12.
What interventions are being tested in trial NCT03681119?
The interventions under investigation include: Dementia symptom management at home hospice edition (BEHAVIORAL), Education and Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03681119?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.